Navigation Links
Oncobiologics and Boston Oncology Team Up to Deliver Biosimilar Therapies for Cancer and Immune Disease to Middle East and North African Markets
Date:11/6/2012

CRANBURY, N.J. and CAMBRIDGE, Mass., Nov. 6, 2012 /PRNewswire/ -- Oncobiologics, Inc. and Boston Oncology, LLC today announced a strategic partnership that will allow Boston Oncology to license, manufacture, and commercialize four of Oncobiologics' biosimilar therapies for cancer and immunological disease in the Middle East and North African (MENA) regions.

Under the agreement, Boston Oncology—a pharmaceutical company that localizes advanced technologies and manufacturing expertise in the developing world—will provide Oncobiologics with upfront licensing payments and development milestone payments, along with royalties after the medicines are commercialized. Boston Oncology plans to oversee clinical trials and the development of manufacturing facilities for these therapies in various MENA markets.

The four biosimilars under agreement are generic versions of the most popular therapies in the world for their indications, representing annual global revenue of more than $25 billion.

"This partnership represents a critical step in Boston Oncology's mission to provide people in emerging nations with cost-effective, locally-produced therapeutics for cancers and inflammatory diseases," said Boston Oncology Founder and CEO Abdullah Baaj, M.D., Pharm. D. "Oncobiologics has a rigorous R&D program that will allow us to bring biosimilar therapies to the Middle East and North Africa."

"We are thrilled to announce this strategic alliance with Boston Oncology, which represents the perfect partner for launching Oncobiologics' first four biosimilar molecules in the MENA region," said Pankaj Mohan, Ph.D., CEO of Oncobiologics. "Boston Oncology has built an innovative, forward-looking model that will bring affordable, therapeutically important medicines to emerging markets," he said.

Specific financial terms were not disclosed. 

About Oncobiologics, Inc.
Oncobiologics is a biopharmaceutical company developing
'/>"/>

SOURCE Oncobiologics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Michael F. Mahoney Assumes Role of Chief Executive Officer and President of Boston Scientific
2. Varian Medical Systems to Proceed with Year End Review and Webcast for Investors at ASTRO Meeting in Boston
3. Boston Scientific to Acquire BridgePoint Medical, Inc.
4. MD+DI Announces Wireless Connectivity in Medical Devices EAST Conference in Boston, MA
5. Boston Scientific to Participate in the 2012 Morgan Stanley Global Healthcare Conference
6. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Stifel Nicolaus Healthcare Conference 2012 In Boston On September 5, 2012
7. Biopharmaceutical Service Providers Announce Collaborative Opening of Boston, MA Office
8. Regado Biosciences, Inc. to Present at the Canaccord Genuity 32nd Annual Growth Conference in Boston, MA
9. Boston Scientific Announces Promising Clinical Data on New Products at the International Spine Intervention Society 20th Annual Scientific Meeting
10. Boston Scientific to Announce Second-Quarter 2012 Financial Results on July 26
11. Last Chance to Save on Boston-Area Mobile Health, Biotech, and Pharmaceutical Conference Registration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)...   Easy Breathe , the fastest growing online sleep ... " - has received more than 4.5 million unique page views ... thrilled that so many people are finding our blog and reading ... "We,re committed to making sleep apnea more widely known and hope ... sleep apnea news , troubleshooting advice , and ...
(Date:8/20/2014)... NEW YORK, Aug 20, 2014 Reportlinker.com ... available in its catalogue: Global Patient ... This report analyzes the worldwide markets ... following Product Segments: Floor Scales, Infant & Baby ... report provides separate comprehensive analytics for the US, ...
(Date:8/20/2014)... 20, 2014  Quantum Materials Corporation (OTCQB:QTMM) today ... patent families from Bayer Technology Services GmbH, the global ... AG of Leverkusen, Germany . ... intellectual property protection for advances Quantum Materials ... (QD) manufacturing. In addition, the Bayer patents cover ...
Breaking Medicine Technology:Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 2Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 3Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 4Global Patient Scales Industry 2Global Patient Scales Industry 3Global Patient Scales Industry 4Global Patient Scales Industry 5Global Patient Scales Industry 6Global Patient Scales Industry 7Global Patient Scales Industry 8Global Patient Scales Industry 9Global Patient Scales Industry 10Global Patient Scales Industry 11Global Patient Scales Industry 12Global Patient Scales Industry 13Global Patient Scales Industry 14Global Patient Scales Industry 15Global Patient Scales Industry 16Global Patient Scales Industry 17Global Patient Scales Industry 18Global Patient Scales Industry 19Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 2Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 3Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 4
... MINNETONKA, Minn. , July 14 American ... provider of world-class devices and therapies for both male and ... study on their market leading MiniArc Single-Incision Sling System for ... MiniArc efficacy rates for negative cough stress test (CST) and ...
... and TULSA, Okla. , July 14 ... strategic alliance to increase the availability of important new ... These tests and the GeneMedRx medication management software can ... personalize their prescribing practices in order to prevent adverse ...
Cached Medicine Technology:12-Month Study Reports 90% Success Rate for AMS' MiniArc Single-Incision Sling 212-Month Study Reports 90% Success Rate for AMS' MiniArc Single-Incision Sling 3Helix Bioscience Appointed DNA Drug Sensitivity Testing Distributor for Genelex Corporation 2
(Date:8/21/2014)... Inc. magazine ranked Centurion Service Group No. 3745 ... of the nation's fastest-growing private companies. The list represents ... of the economy—America’s independent entrepreneurs. Companies such as Yelp, ... other well-known names gained early exposure as members of ... been named to the Inc. 5000 list. We have ...
(Date:8/21/2014)... Sometimes you have to lose the life of ... “From Zero to a Hundred: Finding My Purpose through My Pain,” ... surviving a broken family, a childhood of gang violence and two ... were created to be,” Roy said. “I didn’t give up on ... my purpose today of helping others overcome their trials.” , He ...
(Date:8/21/2014)... NM (PRWEB) August 21, 2014 ... by the Centers for Disease Control and Prevention ... in assessing their compliance with the immunization standards ... and the CDC's General Recommendations on Immunizations. , ... of the many procedures in place to protect ...
(Date:8/21/2014)... August 21, 2014 InSilico ... interventions and addressing the challenges of a ... OncoFinder, for signalome-wide pathway analysis. This ... cross-platform analysis of gene expression data obtained ... published in the journal Frontiers in Molecular ...
(Date:8/20/2014)... August 21, 2014 Most people think ... summer months often get overlooked for a variety of ... for food pantries. Understanding this need, Dr. Bryne ... & natural health care center, wanted to heighten awareness ... hosted its first annual Thanksgiving in July food drive ...
Breaking Medicine News(10 mins):Health News:Centurion Service Group Named to Inc. Magazine's List of the Nation's Fastest-Growing Private Companies 2Health News:Centurion Service Group Named to Inc. Magazine's List of the Nation's Fastest-Growing Private Companies 3Health News:Centurion Service Group Named to Inc. Magazine's List of the Nation's Fastest-Growing Private Companies 4Health News:Zero to a Hundred: True Story of Escaping Death to Meet Life 2Health News:ACC Health Raises the Bar Again by Completing the CQIIP Certification Program 2Health News:OncoFinder, a new algorithm for minimizing errors in high-throughput transcriptome analysis 2Health News:AlignLife Springfield Office Donates 565 Canned Goods to Springfield Food Pantry 2
... The American College of Preventive Medicine (ACPM), a national ... physicians who administer individual and community immunization programs, has ... content of its program, Eli Stone, which suggests a ... The show is scheduled to air Thursday, January 31. ...
... AFL ) today reported its fourth quarter results., ... to the,dollar in the fourth quarter, rising 9.0% to ... of 2006. Net earnings were $382 million,or $.78 per ... share, a,year ago. Net earnings included realized investment losses ...
... for food, sex , , WEDNESDAY, Jan. 30 (HealthDay News) ... in drug addicts, even if they,re unaware that they,ve ... by the U.S. National Institute on Drug Abuse (NIDA). ... to monitor brain activity in cocaine-addicted patients while drug-related ...
... preserving Blue Cross,s nonprofit mission gives Michigan ... LANSING, Mich., Jan. 30 Creation of ... people rejected by,commercial insurers and HMOs because of ... the Michigan Senate Health Policy Committee,today. The Senate ...
... SYK ) announced today that it will participate in the ... - 2:20 p.m. Eastern Time 2008 ... Device Conference New York, New ... available,on Stryker,s website at http://www.stryker.com via the For Investors ...
... a pediatric neurologist at The Childrens Hospital of ... Medicine, has been named a Howard Hughes Medical ... 2007, Cheung was one of 15 physician-scientists selected ... Like all those chosen, Dr. Cheung focuses on ...
Cached Medicine News:Health News:Aflac Incorporated Announces Fourth Quarter Results 2Health News:Aflac Incorporated Announces Fourth Quarter Results 3Health News:Aflac Incorporated Announces Fourth Quarter Results 4Health News:Aflac Incorporated Announces Fourth Quarter Results 5Health News:Aflac Incorporated Announces Fourth Quarter Results 6Health News:Aflac Incorporated Announces Fourth Quarter Results 7Health News:Aflac Incorporated Announces Fourth Quarter Results 8Health News:Aflac Incorporated Announces Fourth Quarter Results 9Health News:Aflac Incorporated Announces Fourth Quarter Results 10Health News:Aflac Incorporated Announces Fourth Quarter Results 11Health News:Aflac Incorporated Announces Fourth Quarter Results 12Health News:Aflac Incorporated Announces Fourth Quarter Results 13Health News:Drug-Related Images Trigger Brain's Reward Center 2Health News:Blue Cross Blue Shield of Michigan Says Guaranteed Access Provisions of Insurance Reform Bills Protect Michigan Consumers Twice-Over 2Health News:Blue Cross Blue Shield of Michigan Says Guaranteed Access Provisions of Insurance Reform Bills Protect Michigan Consumers Twice-Over 3Health News:Stryker to Present at Investor Conference 2Health News:Genetics researcher at Children's Hospital selected as Howard Hughes Medical Institute Investigator 2
... Cycling The Tetrad 2 thermal cycler ... MJ Research Tetrad chassis. As before, the ... the power supply is internal, while a large, ... Better yet, updated automatic lids -- Moto Alphas ...
PTC-100 thermal cycler, holds sixteen 25x75mm microscope slides & 24x0.2ml tubes...
... PCR Sprint with 24-well x 0.2ml sub-ambient ... (includes tube thermistor) Heating rates: up to ... from 4-99C; Excellent uniformity: better than 0.5C ... to use programming: directory program storage of ...
... what a thermal cycler can do for ... an easy graphic interface, and best of ... The iCycler thermal cycler will raise your ... do for you.,, iCycler Thermal Cycler Features:, ...
Medicine Products: